PR Newswire News
- 12:21:00
- CNOOC Limited Announces Bozhong 28-2 South Oilfield Second Adjustment Project Commences Production
- 08:00:00
- CNOOC Limited Announces Lufeng 12-3 Oilfield Development Project Commences Production
- 07:41:00
- Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
2023-09-25
- 23:40:00
- TRIP.COM GROUP WELCOMES ITALIAN TOURISM MINISTER AND DELEGATION TO ITS HEADQUARTERS
- 21:49:00
- Being the Official Supplier for the Hangzhou Asian Games, Yadea Greens the Game with Technological Strength
2023-09-23
- 14:17:00
- Fosun International Ranks Third on the List of 2023 China Top 100 Sustainable Enterprises
- 10:00:00
- Russell Reynolds Associates Bolsters Investment Banking Sector Presence in APAC with Stephen Small and Jonathan Li
2023-09-22
- 23:17:00
- DMCC BOOSTS MAJOR CHINA FDI PUSH DURING SHENZHEN AND HONG KONG ROADSHOWS AS IT SIGNS MOU WITH HKME
- 22:53:00
- China Construction Bank Celebrates 25th Anniversary in Singapore
- 18:45:00
- New Wacom Signature Displays expand digital signature capture options for healthcare, financial services and transaction management
- 18:05:00
- Antengene Announces Phase I Study of Anti-CD24 Monoclonal Antibody ATG-031
- 17:30:00
- Eddid Financial Unveils Innovative AI Financial News Program: Staying Ahead of Market Trends Made Easy
- 17:04:00
- Tuya Smart Presented Energy-saving Solutions at the TUYA Developer Summit in Singapore to Help Customers Achieve Sustainable Future
- 17:00:00
- Yum China to Report Third Quarter 2023 Financial Results
- 16:00:00
- Two Cases of Pancreatic Cancer Treatment with CARsgen's CT041 Published in Journal of Hematology & Oncology
- 15:47:00
- Moomoo Japan Launches Online Brokerage Business, Offering about 7,000 Tradable US Stocks
- 14:42:00
- 2023 China Mermaid Open Championship Atlantis Station and International Mermaid Performance Contest End Successfully
- 14:27:00
- STOIC Foundation: Pioneering ESG Ecosystem Amidst Growing Challenges
- 08:03:00
- China Information Technology Development Limited (CITD) Strengthens Technological Capabilities through HKD$100million Strategic Acquisition
- 07:05:00
- Everest Medicines Enters into Collaboration and License Agreement with Kezar Life Sciences to Develop and Commercialize Zetomipzomib in Greater China and other Asian Markets
2023-09-21
